Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-Ethylmaleimide-induced reduction of 2β-carbomethoxy-3β-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding
- 8 November 1996
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 52 (9) , 1435-1446
- https://doi.org/10.1016/s0006-2952(96)00508-4
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist"Journal of Medicinal Chemistry, 1993
- Neurotransmitter Transporters: Recent ProgressAnnual Review of Neuroscience, 1993
- Molecular characterization of the dopamine transporterTrends in Pharmacological Sciences, 1993
- Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporterPharmacology Biochemistry and Behavior, 1992
- High affinity dopamine reuptake inhibitors as potential cocaine antagonists: A strategy for drug developmentLife Sciences, 1990
- Comparison of characteristics of dopamine uptake and mazindol binding in mouse striatumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989
- Pharmacological and toxicological exploitation of amine transportersTrends in Pharmacological Sciences, 1987
- Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behaviorBiochemical Pharmacology, 1986
- Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport ComplexJournal of Neurochemistry, 1986
- Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranesBiochemical Pharmacology, 1985